We rank companies based on fund manager, research analyst and news sentiment
AFIB stock icon

Acutus Medical


About: Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.

Employees: 233

Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

5.77% less ownership

Funds ownership: 29.36% [Q3] → 23.59% (-5.77%) [Q4]

10% less funds holding

Funds holding: 30 [Q3] → 27 (-3) [Q4]

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

67% less call options, than puts

Call options by funds: $20 | Put options by funds: $61

77% less capital invested

Capital invested by funds: $5.98M [Q3] → $1.39M (-$4.59M) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for AFIB.

Financial journalist opinion